(British Society of Gastroenterology)
- Guidelines Development Group for the British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma
- Quest for HBV functional cure: what have we learnt from silencing RNAs?
- ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-{beta}1 activation
- Sex-based differences in prescribed medications, surgical procedures and disease-related complications in IBD
- Unravelling the obesity paradox in MASLD patients with extrahepatic cancer
- ECM1: a novel matricellular protein with promising antifibrotic potential
- TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality
- GI highlights from the literature
- Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis
- Definite benefits of GLP-1 receptor agonists: what is the risk of gastroparesis and lung aspiration?
- Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanisms
- Large proximal gastric GIST tumours: downsizing by imatinib and subsequent endoresection
- CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases
- Establishment of enterically transmitted hepatitis virus animal models using lipid nanoparticle-based full-length viral genome RNA delivery system
- Underdiagnosed cause of gastrointestinal bleeding
Esprimi il gradimento a questo contenuto
[Totale voti: 0 Media: 0]
